We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Takis Biotech

News List

Italy researchers claim vaccine neutralises coronavirus in human cells pharmaceutical-technology
May 06, 2020
Scientists at Lazzaro Spallanzani National Institute for Infectious Diseases in Italy have claimed that a vaccine candidate could neutralise coronavirus within human cells.
Applied DNA supplies Covid-19 vaccine candidates for preclinical tests pharmaceutical-technology
April 16, 2020
Applied DNA Sciences has shipped five Covid-19 LinearDNA vaccine candidates to Italy-based Takis Biotech for preclinical testing in animals.
Covid-19: Entos and Takis to work on separate vaccines pharmaceutical-technology
March 20, 2020
Entos Pharmaceuticals is set to develop a DNA vaccine for Covid-19 coronavirus infection using its Fusogenix drug delivery platform.
Applied DNA, Takis Biotech design four Covid-19 vaccine candidates pharmaceutical-technology
March 04, 2020
Applied DNA Sciences and Takis Biotech have designed four Covid-19 vaccine candidates to help protect against the novel coronavirus.